Lineage Cell Therapeutics, Inc.
LCTX
$1.11
$0.032.78%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.78% | -4.30% | 37.78% | -4.26% | -11.73% |
| Total Receivables | -56.49% | 40.65% | 1,129.92% | -50.39% | 20.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -65.26% | 86.80% | 10.28% | 26.70% | -30.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 25.70% | 0.00% |
| Total Current Assets | -5.69% | -5.06% | 39.98% | -3.61% | -12.28% |
|
|
|||||
| Total Current Assets | -5.69% | -5.06% | 39.98% | -3.61% | -12.28% |
| Net Property, Plant & Equipment | -3.09% | -1.55% | 5.13% | 9.72% | 0.47% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | -31.89% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.38% | 0.24% | 1,079.59% | 5.48% | 1.39% |
| Total Assets | -3.02% | -2.71% | 25.60% | -1.28% | -18.75% |
|
|
|||||
| Total Accounts Payable | -78.54% | 205.77% | 54.01% | 1.54% | -24.96% |
| Total Accrued Expenses | -3.14% | -17.85% | 59.74% | 2.57% | -0.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.94% | 1.41% | -19.98% | 1.72% | -11.19% |
| Total Finance Division Other Current Liabilities | -2.21% | -48.51% | -11.50% | -28.36% | -24.15% |
| Total Other Current Liabilities | -2.21% | -48.51% | -11.50% | -28.36% | -24.15% |
| Total Current Liabilities | -1.62% | -28.32% | 21.16% | -12.77% | -17.82% |
|
|
|||||
| Total Current Liabilities | -1.62% | -28.32% | 21.16% | -12.77% | -17.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.84% | -2.36% | 0.71% | 40.60% | 3.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -21.42% | -16.24% | -2.76% | 81.95% | 59.56% |
| Total Liabilities | -18.33% | -17.91% | 0.57% | 57.58% | 28.12% |
|
|
|||||
| Common Stock & APIC | 1.14% | 2.75% | 4.31% | 0.74% | 0.25% |
| Retained Earnings | 0.31% | -1.03% | 0.18% | -6.80% | -7.47% |
| Treasury Stock & Other | -12.64% | -1.30% | 8.54% | -4.59% | -52.85% |
| Total Common Equity | 13.07% | 20.93% | 102.13% | -54.45% | -38.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.07% | 20.93% | 102.13% | -54.45% | -38.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 5.25% | 1.91% | 3.30% | 2.28% | 7.28% |
| Total Equity | 13.48% | 21.57% | 108.43% | -55.86% | -39.33% |
|
|
|||||